Market Overview

Why Histogen's Stock Is Trading Higher Today


Histogen (NASDAQ: HSTO) shares are trading higher on Wednesday after the company received a $2 million Department of Defense grant for the advancement of HST-003 in knee injury.

Histogen Inc is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets that replace and regenerate tissues in the body. The company's product pipeline includes Hair Stimulating Complex (HSC), CCM (Skincare), and Matrix regeneration

Histogen shares were up 11.73% at $1.81 at the time of publication on Wednesday. The stock has a 52-week high of $7.50 and a 52-week low of $1.61.


Related Articles (HSTO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at